Results 11 to 20 of about 384,305 (217)

Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial. [PDF]

Circulation
BACKGROUND: Microvascular angina is associated with dysregulation of the endothelin system and impairments in myocardial blood flow, exercise capacity, and health-related quality of life.
Morrow A, Young R, Abraham GR, Hoole S, Greenwood JP, Arnold JR, El Shibly M, Shanmuganathan M, Ferreira V, Rakhit R, Galasko G, Sinha A, Perera D, Al-Lamee R, Spyridopoulos I, Kotecha A, Clesham G, Ford TJ, Davenport A, Padmanabhan S, Jolly L, Kellman P, Kaski JC, Weir RA, Sattar N, Kennedy J, Macfarlane PW, Welsh P, McConnachie A, Berry C, PRIZE Study Group.   +30 more
europepmc   +15 more sources

Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina: A Randomized Clinical Trial.

JAMA Cardiol, 2023
This randomized clinical trial investigates the effect of coronary venous pressure on myocardial resistances in patients with microvascular disease.
Ullrich H, Hammer P, Olschewski M, Münzel T, Escaned J, Gori T.   +5 more
europepmc   +3 more sources

Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study. [PDF]

Cardiol Res Pract, 2023
Background Postacute sequelae of SARS-CoV-2 infection (PASC) are a novel clinical syndrome characterized in part by endothelial dysfunction. Enhanced external counterpulsation (EECP) produces pulsatile shear stress, which has been associated with ...
Wu E, Mahdi A, Nickander J, Bruchfeld J, Mellbin L, Haugaa K, Ståhlberg M, Desta L.   +7 more
europepmc   +2 more sources

Effect of Proprietary Chinese Medicine on Coronary Microvascular Dysfunction in Patients with Microvascular Angina: A Systematic Review and Meta-Analysis. [PDF]

Evid Based Complement Alternat Med, 2023
Background Microvascular angina (MVA) has received increasing attention and interest in recent years, but there are still some shortcomings in the diagnosis and treatments at current stage.
Yu Q, Xu X, Wang S, Fan Y, Zhang J, Leng Y, Liu F, Liu F.   +7 more
europepmc   +2 more sources

Longitudinal Strain Analysis and Correlation with TIMI Frame Count in Patients with Ischemia with No Obstructive Coronary Artery (INOCA) and Microvascular Angina (MVA). [PDF]

J Clin Med, 2023
Background: The aim of the study is to evaluate the subclinical alterations of cardiac mechanics detected using speckle-tracking echocardiography and compare these data with the coronary angiography indices used during coronary angiography in a ...
Sucato V, Novo G, Madaudo C, Di Fazio L, Vadalà G, Caronna N, D'Agostino A, Evola S, Tuttolomondo A, Galassi AR.   +9 more
europepmc   +2 more sources

The Central Nervous System and Psychosocial Factors in Primary Microvascular Angina. [PDF]

Front Cardiovasc Med, 2022
Patients diagnosed with ischemia without obstructive coronary artery disease (INOCA) comprise the group of patients with primary microvascular angina (MVA). The pathophysiology underlying ischemia and angina is multifaceted. Differences in vascular tone,
Cattaneo M, Halasz G, Cattaneo MM, Younes A, Gallino C, Sudano I, Gallino A.   +6 more
europepmc   +2 more sources

The Diagnostic Value of ECG Characteristics for Vasospastic and Microvascular Angina: A Systematic Review. [PDF]

Ann Noninvasive Electrocardiol
Coronary vascular dysfunction comprises VSA and/or MVA and is more common in women than in men with angina without obstructive coronary artery disease (ANOCA).
Schipaanboord DJM, Woudstra J, Appelman Y, Rittersma SZH, van de Hoef TP, van Es R, Coronel R, Damman P, van der Harst P, Onland-Moret NC, den Ruijter HM.   +10 more
europepmc   +2 more sources

Generation of a medicine food homology formula and its likely mechanism in treatment of microvascular angina. [PDF]

Front Pharmacol
Microvascular angina (MVA) is the most common cause of cardiac ischemic chest pain in patients without obstructive coronary artery disease (CAD) and lacks of effective treatment means.
Jin Z, Liu M, Xie B, Wen W, Yan Y, Zhang Y, Li H, Shen Z, Jiang L, Gao M, Chen K, Zhao F.   +11 more
europepmc   +2 more sources

Exploring the mechanism of Shexiang Tongxin dropping pill in the treatment of microvascular angina through network pharmacology and molecular docking. [PDF]

Ann Transl Med, 2022
Background Microvascular angina (MVA) is a group of clinical manifestations of angina pectoris or angina-like chest pain, positive exercise test, and exclusion of epicardial coronary artery spasm, wherein coronary angiography (CAG) does not present ...
Chang C, Ren Y, Su Q.
europepmc   +2 more sources

A systematic review of enrolment criteria and treatment efficacy for microvascular angina. [PDF]

EuroIntervention
BACKGROUND Microvascular angina (MVA) is an important contributor to morbidity and mortality in patients with non-obstructive coronary artery disease. Despite improvements in its recognition and diagnosis, uncertainty remains around the most effective ...
Hammond-Haley M, Chiew K, Ahmed-Jushuf F, Rajkumar CA, Foley MJ, Simader FA, Chotai S, Shun-Shin MJ, Al-Lamee R.   +8 more
europepmc   +2 more sources